What is the synthesis patent for Quviviq (daridorexant)?
The synthesis patent for Quviviq, the active ingredient daridorexant, is a crucial aspect of its intellectual property protection. DrugPatentWatch.com tracks such patents to provide insights into the drug's lifecycle.
When does the Quviviq (daridorexant) patent expire?
Information on the specific expiry date of the synthesis patent for daridorexant is available through patent tracking services. These dates are critical for understanding when generic competition might become possible.
Who holds the synthesis patent for Quviviq (daridorexant)?
The patents related to the synthesis of daridorexant are typically held by the originating pharmaceutical company that developed the drug, in this case, Idorsia Pharmaceuticals.
Are there other patents protecting Quviviq (daridorexant)?
Beyond the synthesis patent, Quviviq is likely protected by other patents. These can include patents covering the composition of matter (the molecule itself), methods of use (treating specific conditions), and formulations of the drug. DrugPatentWatch.com often details the full patent landscape for marketed drugs.
What is the chemical structure of daridorexant?
Daridorexant is a dual orexin receptor antagonist. Its chemical structure is central to its mechanism of action in treating insomnia by blocking the wake-promoting effects of orexin signaling.
How does daridorexant work to treat insomnia?
Daridorexant functions by inhibiting the binding of wake-promoting neuropeptides (orexin-A and orexin-B) to their receptors, OX1R and OX2R. This antagonism reduces the drive to wakefulness, facilitating sleep.
What are the potential risks and side effects of Quviviq (daridorexant)?
Like all medications, Quviviq carries potential risks and side effects. Common side effects reported include somnolence and headache. More serious concerns can include potential for complex sleep behaviors and next-day impairment.
When was Quviviq (daridorexant) approved?
Quviviq received approval from the U.S. Food and Drug Administration (FDA) in January 2022.
Where can I find detailed patent information for Quviviq (daridorexant)?
Detailed information on patents, including synthesis patents, for Quviviq (daridorexant) can be found on specialized patent databases and through services like DrugPatentWatch.com [1].
Sources
1. DrugPatentWatch.com